Navigation Links
Catalent Institute Announces Educational Workshop Series Exploring Dose Form Selection in Early Phase Development
Date:11/26/2015

The Catalent Applied Drug Delivery Institute today announced a series of workshops to discuss bioavailability and the need to integrate dose form selection in early phase drug development. The first of these is to be held in collaboration with OBN, the membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, UK, on December 9th, 2015, and subsequent events will be held in other key life science clusters across Europe.

The workshops, which will combine guest speakers including prominent academics, consultants, and technology representatives, alongside Catalent Institute and drug delivery and formulation experts, will give the opportunity for biotech and life science companies to interact with industry experts and discuss some of the developmental challenges faced by research teams with regard to solubility and bioavailability of drug candidates. With increased pressure upon research scientists to deliver compounds for clinical development faster, it is important to ensure candidates have been fully characterized and have the optimal formulation before proceeding to animal studies, in order to increase the chances of their success at later stages of development.

There will also be an opportunity for companies attending the events to discuss active developmental programs in private with Catalent’s science and technology leaders.

The event starts at 8.30 a.m., and will consider the process of molecule assessment, formulation enhancement, and delivery of animal PK study materials, looking at how this approach may help speed onward development of optimal drug delivery forms. The agenda includes a presentation by Alan Harris, PhD and Keith Purdy, PhD of Alacrity Pharma Associates (http://www.alacritypa.co.uk) who will draw from their considerable wealth of experience within pharmaceutical and biotech research to discuss “Early stage drug development challenges,” before Catalent Institute experts, including Julien Meissonnier, Vice President, Science and Technology and Catalent Institute Board Member, present case studies and technology highlights from Catalent’s wide-ranging and innovative drug delivery technology portfolio.

Further details of upcoming workshops in 2016 will be announced shortly, and to find out more information, or book a place at the Oxford event, visit http://www.eventbrite.com/e/planning-your-journey-before-you-begin-early-dose-form-selection-tickets-19408665842?aff=NEPR

About OBN
OBN is the Membership organisation supporting and bringing together the UK’s emerging life sciences companies, corporate partners and investors. For more information about OBN, please visit http://www.obn.org.uk

About Catalent Applied Drug Delivery Institute
Catalent’s Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments, and foster industry collaboration on major issues pertaining to drug development, formulation, and delivery. It is pursuing a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of emerging technologies.
For more details on the Catalent Institute, visit http://www.drugdeliveryinstitute.com and follow the Catalent Institute on Twitter: @DrugDeliveryIns

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2015/11/prweb13102666.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved


Related medicine news :

1. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
2. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
3. Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
4. Catalent and Minomic Collaborate to Bring New Prostate Cancer Treatment to Market
5. Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference
6. Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions
7. Catalent Announces Two Senior Appointments to its Biologics Business
8. Bioavailability and Controlled Release Symposium Announced by Catalent Applied Drug Delivery Institute
9. Best Practice and Strategies in Risk Mitigation to be Presented by Catalent Expert at Internal Audit Summit
10. New OptiPact™ Technology Introduced by Catalent
11. Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2019)... ... August 19, 2019 , ... ProRehab Louisville and Dr. Stacie Grossfeld have ... and to access to top-notch sports medical care and sport injury experts for rehabilitation. ... demands of ice skating, knows the individualized treatment plan, and understands what a triple ...
(Date:8/19/2019)... ... 19, 2019 , ... Cosmetic Town, an online plastic surgery and information community ... in New York currently providing a lifetime of natural looking results for patients with ... hair. Cosmetic Town makes the process of finding information about these board-certified surgeons in ...
(Date:8/17/2019)... Fla. (PRWEB) , ... August 17, 2019 , ... ... Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd ... 2098 With Three-Year Revenue Growth of 192% Percent , Inc. magazine today revealed ...
(Date:8/16/2019)... ... 16, 2019 , ... The clinical trial supply chain landscape is constantly shifting, ... Join Just In Time Manufacturing Solutions Manager at Almac Clinical Services , Natalie ... EDT (4pm BST/UK) on a journey through time as it relates to clinical trial ...
(Date:8/16/2019)... ... August 16, 2019 , ... Dr. Demetri ... the esteemed Haute Beauty Network. , The Haute Beauty Network, well known for ... Arnaoutakis as a hair restoration expert and our newest addition to the Haute ...
Breaking Medicine News(10 mins):
(Date:8/19/2019)... ... August 19, 2019 , ... ... centers, today announced the findings of research validating the clinical impact of MedAware’s ... were published 7 August 2019 in the Journal of American Medical Informatics ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... Khoury, M.D., will join its Richardson, Texas location, starting Monday, Sep. 2nd. , ... Anesthesiology with a subspecialty board certification in pain management. , Dr. Khoury attended ...
(Date:8/17/2019)... ... 2019 , ... The American Legion Dorchester Post 91 in Cambridge, Md., donated ... the benefit of veteran patients, adding to a donation in the same amount it ... most recent donation from Post 91 will enable the VA Maryland Health Care System ...
Breaking Medicine Technology: